Enzychem Lifesciences Corporation (KOSDAQ:183490)

South Korea · Delayed Price · Currency is KRW

990.00

-27.00 (-2.65%)

Mar 25, 2026, 7:48 AM KST

Enzychem Lifesciences Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	69,002	67,751	77,378	76,039	26,638	22,975
Revenue Growth	-5.10%	-12.44%	1.76%	185.46%	15.94%	-11.01%
Gross Profit	3,379	3,383	4,310	4,348	2,416	286.72
Operating Income	-18,861	-18,270	-16,376	-14,733	-14,662	-20,754
Net Income	-17,997	-18,132	-22,107	-9,326	-24,934	-26,923
Earnings Per Share	-227.47	-234.50	-270.00	-110.00	-316.34	-533.20
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	93,874	92,821	117,075	137,350	192,856	94,587
Total Debt	11,778	4,839	4,880	5,657	37,779	51,977
Net Cash (Debt)	82,096	87,982	112,195	131,693	155,077	42,609
Net Cash Growth	-24.09%	-21.58%	-14.81%	-15.08%	263.95%	-10.18%
Net Cash Per Share	1037.65	1137.89	1370.30	1550.62	1967.48	843.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-19,207	-11,012	-573.93	-10,258	-14,320	-18,589
Capital Expenditures	-551.18	-762.68	-323.82	-2,248	-7,957	-5,818
Free Cash Flow	-19,758	-11,775	-897.74	-12,506	-22,277	-24,407
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	4.90%	4.99%	5.57%	5.72%	9.07%	1.25%
Operating Margin	-27.33%	-26.97%	-21.16%	-19.38%	-55.04%	-90.33%
Pretax Margin	-26.03%	-26.92%	-28.54%	-12.99%	-96.03%	-128.42%
Profit Margin	-26.08%	-26.76%	-28.57%	-12.26%	-93.60%	-117.18%
FCF Margin	-28.63%	-17.38%	-1.16%	-16.45%	-83.63%	-106.23%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1.11	1.75	1.47	2.03	5.24	19.91